| 2025-11-14 |
详情>>
内部人交易：
LIVEK WILLIAM PAUL股份减少9900.00股
|
| 2025-11-07 |
股东大会：
将于2025-12-19召开股东大会
会议内容 ▼▲
- 1.To approve, in accordance with Nasdaq Listing Rules 5635(b) and 5635(d), the issuance of shares of common stock, par value $0.001 per share (“Common Stock”) and Series C Convertible Preferred Stock, par value $0.001 per share (“Series C Preferred Stock”) of the Company to each of Charter Communications Holding Company, LLC, Liberty Broadband Corporation and Pine Investor, LLC (collectively, the “Preferred Stockholders”) in accordance with the terms of the Stock Exchange Agreements by and between the Company and each of the Preferred Stockholders (the “Share Issuance”);
2.To approve the Exchange Documents and the Exchange (each as defined below) by a vote of the “disinterested stockholders” as such term is defined in Section 144(e) of the Delaware General Corporation Law (the “Disinterested Stockholder Approval”);
3.To adopt an amendment to our Amended and Restated Certificate of Incorporation to permit the Share Issuance and authorize a sufficient number of shares of Common Stock and preferred stock, par value $0.001 per share, of the Company (the “COI Amendment”);
4.To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Share Issuance, the Disinterested Stockholder Approval and/or the COI Amendment (the “Adjournment Proposal”).
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本501.57万股
变动原因 ▼▲
- 原因：
- From June 30,2025 to September 30,2025
Payments for taxes related to net share settlement of equity awards
Restricted stock units distributed
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-5.24美元,归母净利润-2693.6万美元,同比去年增长64.77%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘后发布财报
|
| 2025-09-29 |
复牌提示：
2025-09-29 10:01:29 停牌，复牌日期 2025-09-29 10:06:29
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益-4.41美元,归母净利润-2241.8万美元,同比去年增长-99.34%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-1.66美元,归母净利润-843.2万美元,同比去年增长-59.27%
|
| 2025-04-30 |
股东大会：
将于2025-06-17召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees named in this proxy statement as Class III directors to serve for terms expiring at our 2028 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified;
2.To approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.To approve an amendment to our Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of our common stock, par value $0.001 per share (the “Common Stock”) available for grant by 2,000,000;
5.To adopt an amendment to our Amended and Restated Certificate of Incorporation to increase (i) the total number of shares authorized for issuance from 118,750,000 to 121,750,000 and (ii) the number of shares of Common Stock authorized for issuance from 13,750,000 to 16,750,000;
6.To adopt an amendment to the Certificate of Designations (the “COD”) of our Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) (i) to increase the number of authorized shares of preferred stock designated as Series B Preferred Stock from 100,000,000 to 104,000,000 and (ii) to clarify that shares of Series B Preferred Stock issued as payment for accrued dividends on the Series B Preferred Stock, or in lieu thereof, will count toward the $100,000,000 threshold required for us to undertake a Mandatory Conversion (as defined in the COD);
7.To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of Common Stock or Series B Preferred Stock as payment for accrued dividends on the Series B Preferred Stock or in lieu thereof, if elected by the Disinterested Directors (as defined in the COD) or agreed between the Disinterested Directors and the holders of Series B Preferred Stock, as applicable;
8.To transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2025-03-06 |
详情>>
业绩披露：
2024年年报每股收益-15.53美元,归母净利润-7784.8万美元,同比去年增长18.60%
|
| 2025-03-06 |
详情>>
业绩披露：
2022年年报每股收益-17.71美元,归母净利润-8166.4万美元,同比去年增长-30.33%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-15.33美元,归母净利润-7645.4万美元,同比去年增长-21.46%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益-2.28美元,归母净利润-1124.6万美元,同比去年增长81.65%
|
| 2024-08-09 |
详情>>
业绩披露：
2023年中报每股收益-12.94美元,归母净利润-6127.7万美元,同比去年增长-178.29%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益-1.08美元,归母净利润-529.4万美元,同比去年增长57.63%
|
| 2024-04-29 |
股东大会：
将于2024-06-12召开股东大会
会议内容 ▼▲
- 1.To elect the four nominees named in this proxy statement as Class II directors to serve for terms expiring at our 2027 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified;
2.To approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3.To recommend, on a non-binding advisory basis, whether the advisory vote on executive compensation should occur every year, every two years or every three years;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
5.To approve an amendment to our Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of our common stock, par value $0.001 per share (the “Common Stock”) available for grant by 900,000;
6.To adopt an amendment to the Certificate of Designations of our Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) to clarify that the price thresholds in Sections 4(c)(i)(a), (b) and (c) of the Certificate of Designations shall be adjusted as appropriate to give effect to the reverse stock split effectuated by the company on December 20, 2023;
7.To transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2024-03-12 |
详情>>
业绩披露：
2023年年报每股收益-19.88美元,归母净利润-9563.1万美元,同比去年增长-17.1%
|
| 2023-12-20 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.66美元,归母净利润-6294.5万美元,同比去年增长19.62%
|
| 2023-10-31 |
股东大会：
将于2023-12-12召开股东大会
会议内容 ▼▲
- 1.To adopt an amendment to our Amended and Restated Certificate of Incorporation to (i) effect a reverse stock split of our common stock, par value $0.001 per share (“Common Stock”), by combining shares of Common Stock issued and outstanding or held in treasury into a lesser number of shares of Common Stock at a ratio in the range of 1-for-2 and 1-for-30, with the exact ratio to be selected by our Board of Directors (the “Reverse Stock Split”) and (ii) reduce the number of authorized shares of Common Stock by the same ratio as the Reverse Stock Split (the “Authorized Share Reduction” and such amendment, the “Certificate of Amendment” or “Proposal No. 1”);
2.To approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are insufficient votes to approve Proposal No. 1 (the “Adjournment Proposal” or “Proposal No. 2”).
|
| 2023-04-28 |
股东大会：
将于2023-06-15召开股东大会
会议内容 ▼▲
- 1.To elect the four nominees named in this proxy statement as Class I directors to serve for terms expiring at our 2026 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified.
2.To approve, on a non-binding advisory basis, the compensation paid to our named executive officers.
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
4.To approve an amendment to our Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of our common stock, par value $0.001 per share (the “Common Stock”) available for grant by 10,000,000.
5.To adopt an amendment to the Certificate of Designations of our Series B Convertible Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) to (i) permit us to pay annual dividends on the Series B Preferred Stock in the form of cash, shares of Common Stock, additional shares of Series B Preferred Stock, or a combination thereof, in each case in accordance with the amendment and as elected by members of our Board of Directors who have not been designated by, and are not affiliated with, any holder of Series B Preferred Stock (the “Disinterested Directors”), and (ii) make certain other clarifying and conforming changes to the Certificate of Designations, including with respect to intended tax treatment.
6.To adopt an amendment to our Amended and Restated Certificate of Incorporation to authorize additional shares of preferred stock, par value $0.001 per share (“preferred stock”) in order to permit us to issue additional shares of Series B Preferred Stock and other preferred stock and pay annual dividends in the form of Series B Preferred Stock, in accordance with the Certificate of Designations amendment and if elected by the Disinterested Directors.
7.To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of Common Stock or Series B Preferred Stock as annual dividends on the Series B Preferred Stock, in accordance with the terms of the Certificate of Designations amendment and if elected by the Disinterested Directors.
8.To transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2022-04-29 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.to elect the three nominees named in this proxy statement as Class III directors to serve for terms expiring at our 2025 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified;
2.to approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3.to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.to approve an amendment to our Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of our common stock available for grant by 7,600,000;
5.to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.to elect the three nominees named in this proxy statement as Class II directors to serve for terms expiring at our 2024 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified;
2.to approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3.to ratify the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
4.to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2021-02-19 |
股东大会：
将于2021-03-09召开股东大会
会议内容 ▼▲
- 1.to approve, in accordance with Nasdaq Listing Rules 5635(b) and 5635(d), the issuance of the Series B Convertible Preferred Stock, par value $0.001 per share, of the Company (“Convertible Preferred Stock”) to each of Charter Communications Holding Company, LLC, a Delaware limited liability company (“Charter”), Qurate Retail, Inc., a Delaware corporation (“Qurate”), and Pine Investor, LLC, a Delaware limited liability company wholly owned by funds advised by Cerberus Capital Management, L.P. (“Pine” and together with Charter and Qurate, collectively, the “Investors”), in accordance with the terms of the Series B Convertible Preferred Stock Purchase Agreements by and between the Company and each of the Investors (the “Share Issuance”);
2.to adopt an amendment to our Amended and Restated Certificate of Incorporation to permit us to create the Convertible Preferred Stock and other preferred stock and, in order to permit the Share Issuance, authorize a sufficient number of shares of preferred stock, par value $0.001 per share, and common stock, par value $0.001 per share, of the Company (the “Common Stock”) into which such shares of Convertible Preferred Stock may be converted (the “Charter Amendment”);
3.to approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Share Issuance and/or the Charter Amendment (the “Adjournment Proposal”).
|
| 2020-05-29 |
股东大会：
将于2020-07-09召开股东大会
会议内容 ▼▲
- 1.to elect the two nominees named in this proxy statement as Class I directors to serve for terms expiring at our 2023 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified;
2.to approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3.to ratify the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
4.to approve an amendment and restatement of our 2018 Equity and Incentive Compensation Plan (the “2018 Plan”) to increase the number of shares of our common stock available for grant by 9,600,000 and to make other changes to the 2018 Plan as described in this proxy statement;
5.to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2019-04-30 |
股东大会：
将于2019-06-10召开股东大会
会议内容 ▼▲
- 1)to elect the three nominees named in this proxy statement as Class III directors to serve for terms expiring at our 2022 annual meeting of stockholders, to hold office until their respective successors have been duly elected and qualified;
2)to approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3)to ratify the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
4)to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|
| 2018-04-20 |
股东大会：
将于2018-05-30召开股东大会
会议内容 ▼▲
- 1.to elect (A) two Class III directors to serve for terms expiring at our 2019 annual meeting of stockholders, (B) three Class I directors to serve for terms expiring at our 2020 annual meeting of stockholders, and (C) three Class II directors to serve for terms expiring at our 2021 annual meeting of stockholders, in each case, to hold office until their respective successors have been duly elected and qualified;
2.to approve, on a non-binding advisory basis, the compensation paid to our named executive officers;
3.to recommend, on a non-binding advisory basis, whether the advisory vote on executive compensation should occur every year, every two years or every three years;
4.to approve our 2018 Equity and Incentive Compensation Plan;
5.to approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of shares of Common Stock authorized for issuance thereunder from 100,000,000 to 150,000,000;
6.to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
7.to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof.
|